7FS-10535-46034
3 vaccinations
9 coded responses
30 check-ins
9 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 088 / NJ
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-13
- 2021-01-18
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
-
2021-02-08
Survey response — day 14, dose 2MedDRA: Nasal congestion, Rhinorrhoea — Feeling: FairFree text: Nasal congestion and runny nose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-03-01
-
2021-03-10
Survey response — day 42, dose 2MedDRA: Hypersensitivity — Feeling: FairFree text: AllergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
-
2021-07-26
Survey response — 6 months, dose 2MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-21
Dose 3 — Pfizer-BioNTech
-
2021-12-29
Survey response — day 7, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: 13 weeks pregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-01-04
-
2022-01-11
Survey response — day 21, dose 3MedDRA: Chills, Cough, Headache, Myalgia, Pyrexia, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, congestion, chills, headaches, myalgias, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Report sent to call center — day 21, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-12
-
2022-01-13
Call successfulParticipant prefers to complete VAERS report online
- 2022-01-18
-
2022-01-25
Survey response — day 35, dose 3MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-02-01
-
2022-03-22
Survey response — 3 months, dose 3MedDRA: Cough, Wheezing — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough and wheezingMedDRA releases: 2024-11 · check-in free text available
-
2022-03-22
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-23
-
2022-06-21
Survey response — 6 months, dose 3MedDRA: Bronchial hyperreactivity — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Reactive airwayMedDRA releases: 2024-11 · check-in free text available
-
2022-06-21
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-06-22
Call successfulDoes not wish to fill out VAERS report
-
2022-06-22
Call successfulDoes not wish to fill out VAERS report
-
2022-12-21
Survey response — 12 months, dose 3MedDRA: Bronchial hyperreactivity, COVID-19 — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Reactive Airway Disease since contracting COVID in 1/2022MedDRA releases: 2024-11 · check-in free text available
-
2022-12-21
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-22
- 2022-12-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-12-21 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-11 | Successful 2022-01-13 |
Participant prefers to complete VAERS report online |
| 2022-03-22 | Successful 2022-06-22 |
Does not wish to fill out VAERS report |
| 2022-06-21 | Successful 2022-06-22 |
Does not wish to fill out VAERS report |
| 2022-12-21 | Unsuccessful |
Free text
Release 3 — day 14, dose 2
Symptoms: Nasal congestion and runny nose.
Release 5 — day 42, dose 2
Symptoms: Allergies
Release 9 — 6 months, dose 2
Symptoms: Nasal congestion
Release 10 — day 7, dose 3
Systemic reaction (other): 13 weeks pregnant
Release 10 — day 21, dose 3
Symptoms: Fever, congestion, chills, headaches, myalgias, cough
Release 11 — day 35, dose 3
Symptoms: Cough
Release 11 — 3 months, dose 3
Symptoms: Cough and wheezing
Release 12 — 6 months, dose 3
Symptoms: Reactive airway
Release 12 — 12 months, dose 3
Symptoms: Reactive Airway Disease since contracting COVID in 1/2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchial hyperreactivity | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release